FDA.reportPublic FDA data

1.1 ML elranatamab-bcmm 40 MG/ML Injection

RxCUI
2644885
RxNorm name
1.1 ML elranatamab-bcmm 40 MG/ML Injection
Display name
1.1 ML elranatamab-bcmm 40 MG/ML Injection
Full name
1.1 ML elranatamab-bcmm 40 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:14

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761345Elrexfioelranatamab-bcmm351(a)Rx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ElrexfioELRANATAMAB-BCMMU.S. Pharmaceuticalsaa044060-5b4b-4692-bf0f-9a50e140b10e2026-05-14Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2644885
ElrexfioELRANATAMAB-BCMMPfizer Laboratories Div Pfizer Incf6fea598-ff58-4a20-b5e8-8a51f37d8beb2026-02-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2644885

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
aa044060-5b4b-4692-bf0f-9a50e140b10eelranatamab-bcmm 44 MG in 1.1 ML Injection [PSN] · 1.1 ML elranatamab-bcmm 40 MG/ML Injection [SCD] · elranatamab-bcmm 44 MG per 1.1 ML Injection [SY]35These highlights do not include all the information needed to use ELREXFIO safely and effectively. See full prescribing information for ELREXFIO. ELREXFIO ® (elranatamab-bcmm) injection, for subcutaneous use Initial U.S. Approval: 202320260514
f6fea598-ff58-4a20-b5e8-8a51f37d8bebelranatamab-bcmm 44 MG in 1.1 ML Injection [PSN] · 1.1 ML elranatamab-bcmm 40 MG/ML Injection [SCD] · elranatamab-bcmm 44 MG per 1.1 ML Injection [SY]34These highlights do not include all the information needed to use ELREXFIO safely and effectively. See full prescribing information for ELREXFIO. ELREXFIO ® (elranatamab-bcmm) injection, for subcutaneous use Initial U.S. Approval: 202320260226